Although the consequences of an inaccurate translation can be extremely serious in terms of human lives, credibility, and economic revenues, translation is often the last step in the planning of an international clinical trial, and it is rarely given the attention that it requires. Many times, clinical trial protocols are developed in one country and then implemented in locations with vastly differing languages and cultures. The importance of clinical translators, interpreters and localizers thus becomes a key element in the implementation of these trials and the way pharmaceutical companies interpret patient report outcomes.

Learning objective: This presentation will provide translators and interpreters tools to familiarize themselves with clinical trials and learn about cultural adaptation, localization as a significant component in this medical/pharmaceutical specialization.

The presenters:

Afaf Steiert is President and founder of Afaf Translations, where she works as a conference Arabic interpreter, and oversees all translation services at Afaf Translations. She speaks 5 languages and has good knowledge of all Arabic dialects. She obtained her M.Sc. in plant molecular biology from University of Basel, Switzerland.

Matthias Steiert is co-founder of Afaf Translations specialized in language services to the pharmaceutical industry. He holds a Ph.D. in biochemistry from the University of Basel, Switzerland.

Where: Zoom. You will receive the Zoom link, and a password by email after registering. Attendees will need access to a computer with internet and speakers to listen to the presentation.

Cost:    NCTA Members – $30;      Non-NCTA Members – $45 (click to join NCTA)

Registration? Via the NCTA website (by October 1st). After registering, you will receive an email confirmation; if you do not receive a confirmation, your registration did not go through.